Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,895.20
(
0.09%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
94.01
(
-1.06%
)
Bitcoin
76,299.73
(
-0.04%
)
News Focus
News Focus
Post# of 517474
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

sage4

Send PM Follow Ignore
Followers 34
Posts 2985
Boards Moderated 0
Alias Born 02/21/2011

sage4

Re: rx7171 post# 500842

Wednesday, 09/17/2025 2:06:54 AM

Wednesday, September 17, 2025 2:06:54 AM

Post# of 517474

EMA has ZERO additional AD drug applications in hand and none of us here see any in the foreseeable future.
For European AD patients and their caregivers Blarcamasine is the only hope for that foreseeable future.


That's a very good point that I haven't thought about.
They need something right now. Why not an oral pill a day with safety, efficacy and cost effectiveness! Thanks.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News